The Conformable GORE® TAG® Thoracic Endoprosthesis is an option for the endovascular treatment of thoracic aneurysms, transections and Type B dissections.

As a proven endovascular treatment for the thoracic aorta, the Conformable GORE® TAG® Thoracic Endoprosthesis provides physicians with many benefits, including:

  • Optimized Conformability: Designed to treat compromised aortas and provide optimal outcomes in a wide range of pathologies
  • Patient Fit: Engineered to perform in 6 – 33% oversizing conditions allowing physicians to choose radial force to fit patient anatomy
  • Proven Results: Strong clinical data and more than 25 years of experience in thoracic endovascular aortic repair (TEVAR); more than 300,000 GORE® TAG® Thoracic Devices have been distributed worldwide1

The time-tested Conformable GORE® TAG® Thoracic Endoprosthesis provides less-invasive endovascular treatment for diseases of the descending thoracic aorta, including aneurysms, transections and Type B dissections. Our highly respected and trusted device is known for its performance and durability, and is the most studied thoracic endograft available.2

Related to this product 

  1. Data on file 2025; W. L. Gore & Associates, Inc; Flagstaff, AZ.
  2. With the first clinical implant occurring in 1998, the GORE® TAG® Device has been studied in ten FDA-approved clinical studies, one European clinical trial (ADSORB) and one worldwide registry (GREAT).
IFU Consult instructions

Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

INDICATIONS FOR USE IN THE U.S.: The GORE® TAG® Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta, including: Isolated lesions in patients who have appropriate anatomy, including: Adequate iliac/femoral access; Aortic inner diameter in the range of 16-42 mm; ≥ 20 mm non-aneurysmal aorta proximal and distal to the
lesion. Type B dissections in patients who have appropriate anatomy, including: Adequate iliac/femoral access; ≥ 20 mm landing zone proximal to the primary entry tear; proximal extent of the landing zone must not be dissected; Diameter at proximal extent of proximal landing zone in the range of 16-42 mm. 

CONTRAINDICATIONS: The GORE® TAG® Thoracic Endoprosthesis is contraindicated in: Patients with known sensitivities or allergies to the device materials (Table 1); Patients who have a condition that threatens to infect the graft. 

25AR1080-EN01